In recent years, several studies have demonstrated the roles of TAMs and CD163 in the pathogenesis of hematopoietic malignancies including T-cell leukemia/lymphoma, acute myeloid leukemia, and classical Hodgkin lymphoma [17,37,38,39,40,41,42,43]. Here, CD163 is linked to T-cell leukemia.